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Endotoxins are lipopolysaccharide components
of the outer membranes of gram-negative bac-
teria. Endotoxin has been implicated in bysin-
nosis, organic dust toxic syndrome, and illness
in swine confined animal feeding operations
workers (Douwes et al. 2002). Endotoxin in
settled dust in residential environments has
been associated with an increase in asthma
symptoms, asthma medications, and reduc-
tions in lung function in those with atopy or
asthma (Douwes et al. 2000; Gehring et al.
2001a; Michel et al. 1991, 1996; Park et al.
2001a; Rizzo et al. 1997). Despite these
adverse effects, early exposure may reduce
future allergies and asthma (Lapa e Silva
et al. 2000; Litonjua et al. 2002; Reed and
Milton 2001; Von Ehrenstion et al. 2000;
Von Mutius et al. 2000). Most studies were
of adults or school-age children, with two
focusing on infants. In the present study we
examined the association between airborne
endotoxin and the incidence of respiratory ill-
nesses in children during the first 2 years of
life. We accounted for exposure to a potential
confounder, indoor fungus, which has been
associated with respiratory symptoms and
may be associated with the presence of indoor
endotoxin (Gehring et al. 2001b; Verhoeff
and Burge 2004).
Materials and Methods
Study design. Data for the present study were
abstracted from an ongoing study of the inﬂu-
ence of indoor environmental factors on respi-
ratory illness during the first 2 years of life.
The study began in 1997 in the province of
Prince Edward Island, Canada, which has a
population of approximately 150,000. The
study was approved by the ethics review
boards of the Ottawa Hospital and the Health
Protection Branch of the Canadian govern-
ment. Recruitment occurred during the late
autumn and winter (cold season) of each year
when the ground was frozen. Because of
resource constraints, we recruited approxi-
mately 60 consecutive newborns each year. All
physicians who practice obstetrics in the
province participated in recruitment. Women
in the third trimester of pregnancy received
letters from the physicians’ ofﬁces describing
the study and requesting participation.
Interested women were contacted by tele-
phone to obtain informed consent. Excluded
from the study were babies born > 4 weeks
premature, those with neonatal respiratory
difﬁculties requiring prolonged hospitalization
at birth, and those whose families expected to
change residence within 2 years of birth. Only
one child per household was studied. Baseline
information was obtained on sociodemo-
graphics and family history. The participating
parents maintained a daily symptom diary
from birth until 2 years or until the study
ended, on large multipurpose calendars. Each
study family was phoned twice monthly to
document information from the diary. If par-
ents had omitted recording symptoms on a
daily basis, they provided information for the
previous 2 weeks based on recall. Parental
reporting of child care attendance was also
recorded every 2 weeks.
Definition of respiratory illness. We
adapted the method of Samet et al. (1992) to
deﬁne a respiratory illness episode, the purpose
being to identify discrete acute illnesses as
opposed to persistent ongoing symptoms, such
as a chronically runny nose. We defined the
beginning of an illness episode as 2 consecutive
days with any one of the four following symp-
toms: stuffy nose, cough, wheeze, and short-
ness of breath. The illness episode starts on the
ﬁrst of these 2 consecutive days and ends when
there are 2 consecutive days with none of these
symptoms, the last day of the illness episode
being the last day with a symptom.
The primary outcome of interest was the
number of illness episodes prorated on an
annual basis (number multiplied by 365/days
of observation). A secondary outcome meas-
ure, illness days, was deﬁned as the sum of all
days occurring within illness episodes, also
prorated on an annual basis. For example, if a
child had two illness episodes each lasting
3 days, six illness days would be assigned. If a
child had two illness episodes each lasting
5 days, 10 illness days would be assigned.
Air sampling for endotoxin and ergosterol.
Sampling was done within the ﬁrst year of birth,
and for 81%, within the first 4 months. Air
from the child’s bedroom was sampled for both
endotoxin and ergosterol through a three-piece
cartridge equipped with a polycarbonate ﬁlter
for approximately 5–7 days with a Buck model
SS sampling pump (AP Buck, Orlando, FL,
USA) calibrated at 2 L/min at the beginning
and end of the sampling. Forty-eight hours after
the pump was installed, the flow rate was
checked to ensure it was within 5% of the ini-
tial reading. Very high dust concentrations can
clog the ﬁlter and reduce the pump ﬂow. If this
happened, the pump was stopped and air endo-
toxin concentration was calculated based on the
reduced sampling time. The total volume of air
sampled ranged from 6.0 to 23.9 m3, limited
by the need to maintain an acceptable flow
rate. Once collected, the cartridges and ﬁlters
were sealed in new plastic bags and stored at
room temperature under dry conditions.
For endotoxin analysis, the filters were
extracted with depyrogenated water (LRW,
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MA, USA) assisted by sonication. Samples
taken before April 2001 were analyzed by the
Limulus amoebocyte lysate (LAL) assay gel clot
method from Associates of Cape Cod. The
detection limit was 0.25 EU/ﬁlter. All subse-
quent analyses were done by the LAL chro-
mogenic method, also from Associates of Cape
Cod. The detection limit was 0.1 EU/filter.
All analyses were performed by the same ana-
lyst in the same laboratory according to the
manufacturer’s instructions. Apart from differ-
ences in the lower limit of detection, the two
methods gave similar results.
We analyzed ergosterol, an indicator of fun-
gal biomass, by gas chromatography and mass
spectroscopy as described by Foto et al. (2005).
The volume of air sampled ranged from 10.7 to
25.4 m3. Ergosterol was determined using an
Agilent model 5973 quadrupole mass spec-
trometer (Agilent Technologies, Inc., Palo Alto,
CA, USA) operating in the electron ionization
mode at 70 eV. Compounds were separated
on an Agilent 6890 series gas chromatograph
equipped with a 30 m × 0.25 mm inner
diameter × 0.25 µm ZB-5 capillary column.
The concentration of ergosterol was determined
against an authentic external standard in the
selective ion mode using m/z 363 and 396. The
detection limit in selective ion mode was
4.5 ± 0.6 ng/mL. Ergosterol standard (Sigma
Chemical Company, St. Louis, MO, USA) was
recrystalized, freeze-dried, and stored at 4°C.
Deﬁnition of covariates other than ergos-
terol. During the postnatal interviews, several
characteristics were recorded every 2 weeks for
a period of 2 years: the presence of furry or
feathered pets in the house, the presence of
smokers inside the house, whether the baby
was breast-fed, and the number of hours per
week the child was cared for outside the home.
Based on this information, we created a sum-
mary variable for each of the characteristics.
For the ﬁrst three characteristics, we calculated
the percentage of postnatal interviews where
the characteristic was declared. For example, if
20 of 50 postnatal interviews mentioned the
presence of pets inside the house for a particu-
lar child, the value of the pet variable would be
0.4. The last characteristic, the number of
hours per week that the baby was cared for
outside the home, was averaged over the entire
2-year period to create the child-care variable.
For presentation, we then categorized some
summary variables. The pet variable was cate-
gorized into “never declared pets,” “sometimes
declared pets,” and “always declared pets,”
which divided responses almost equally into
thirds. The exposure-to-smoke variable was
categorized into terciles. The breast-feeding
and the child-care variables were kept as con-
tinuous data. The age variable was deﬁned as
the age of the child in the middle of the span
of the follow-up period. “Mold surface area”
refers to the total surface area of the home with
mold visible to trained home inspectors.
Statistical analysis. We tested the associa-
tion between the number of illness episodes
per year and airborne bedroom endotoxin
concentration using multiple linear regression
analysis. Valid endotoxin results were obtained
for 351 houses. A total of 19 homes were
excluded from the analysis—15 because of
missing temperature data and four because of
missing income data—leaving 332 homes for
analysis. Eleven babies of 332 (3.3%) exited
the study before turning 2 years of age (mean
age, 1.1 years), and 56 babies had not reached
2 years of age (mean 1.7 years) by the last day
of data collection used for this analysis. This is
an ongoing study with children entering and
exiting at different times. The illness episodes
and covariates were annualized and thus
adjusted for duration of follow-up. To test the
effect of the 11 babies who exited early, we
repeated the analysis with and without them,
and no differences were found in the
illness–endotoxin association.
Mold surface area was expressed as ranks
from highest to lowest. Endotoxin values fol-
lowed a log-normal distribution, so they were
log-transformed. A multiple linear regression
model with the number of respiratory illness
episodes per year as the dependent variable and
the natural logarithm of endotoxin concentra-
tion as the primary independent variable of
interest was built with the stepwise method. A
categorical variable—the year of sample collec-
tion—was added to the model to account for
any seasonal variations in illness from year to
year and also the change in the lower limit of
detection of the endotoxin analytic technique
after 2001. Endotoxin and year of home sam-
pling were held in the model along with any
variables with p-values < 0.10, resulting in the
ﬁnal model, with variables endotoxin, year of
home sampling, temperature, age, mean hour
per week that the baby was cared for more
than 1 day a week outside the home, percent-
age of postnatal interviews in which the baby
was breast-fed, income, and categorized per-
centage of postnatal interviews where smokers
were declared in home.
A potential confounder was defined as a
variable (Tables 1 and 2) that, if added to the
model, would change the parameter (β) of the
natural logarithm of endotoxin by > 10%. No
confounders were found for the illness episodes
model. The residuals from the regression equa-
tion were normally distributed (Shapiro-Wilk
statistic = 0.9932, p = 0.1362). We also exam-
ined the homogeneity of variance assumption,
and the chart of residuals against predicted val-
ues showed no particular pattern. Interactions
biologically plausible were also tested, and
none were found to be statistically signiﬁcant
at the 5% level. We found no evidence of
interaction between allergies or asthma in par-
ents and endotoxin. Careful examination of
each of the partial residual plots (i.e., the com-
ponent-plus-residual plot) did not reveal any
sign of nonlinearity in the relationship between
illnesses and air endotoxin. Further, adding a
square term for endotoxin did not improve sig-
niﬁcantly the R2 of the model.
The endotoxin measurement was made
only at the beginning of the 2-year follow-up.
To determine the robustness of the endo-
toxin–illness association, we measured it at sev-
eral time points between the initial endotoxin
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Table 1. Characteristics of 332 children overall and stratiﬁed by terciles of endotoxin for categorical variables
[no. (%)].
Characteristic Overall 1st tercile 2nd tercile 3rd tercile p-Valuea
Male sex 167 (50.3) 53 (47.8) 54 (49.1) 60 (54.1) 0.61
Parent with asthma or allergiesb 174 (52.7) 64 (57.7) 50 (45.9) 60 (54.6) 0.19
Parent with university education 197 (59.3) 66 (59.5) 64 (58.2) 67 (60.4) 0.95
Family income 0.61
< $30,000 67 (20.2) 19 (17.1) 20 (18.2) 28 (25.2)
$30,000–49,999 114 (34.3) 39 (35.1) 39 (35.5) 36 (32.4)
≥ $50,000 151 (45.5) 53 (47.8) 51 (46.4) 47 (42.3)
Environment
Furry or feathered pets 0.70
Never 86 (25.9) 33 (29.7) 24 (21.8) 29 (26.1)
Sometimes 126 (38.0) 42 (37.8) 42 (38.2) 42 (37.8)
Always 120 (36.1) 36 (32.4) 44 (40.0) 40 (36.0)
Exposure to smoke 0.73
Low 114 (34.3) 33 (29.7) 40 (36.4) 41 (36.9)
Medium 110 (33.1) 40 (36.0) 33 (30.0) 37 (33.3)
High 108 (32.5) 38 (34.2) 37 (33.6) 33 (29.7)
Year tested < 0.0001
1998 52 (15.7) 9 (8.1) 15 (13.6) 28 (25.2)
1999 53 (16.0) 8 (7.2) 19 (17.3) 26 (23.4)
2000 45 (13.6) 21 (18.9) 14 (12.7) 10 (9.0)
2001 58 (17.5) 36 (32.4) 13 (11.8) 9 (8.1)
2002 58 (17.5) 24 (21.6) 14 (12.7) 20 (18.0)
2003 66 (19.9) 13 (11.7) 35 (31.8) 18 (16.2)
ap-Value of the Pearson chi-square test of association between the characteristic and endotoxin. bThere are two missing
values for parent with asthma or allergies.measurement and symptom assessment. We
would assume that a true causal association
would remain stable or weaken over time. If
the association increased or fluctuated ran-
domly with time of follow-up, this would
reduce the probability of a causal association.
We measured the results from 90-, 180-, 270-,
360-, 450-, 540-, 630-, and 720-day windows
around the time of endotoxin sampling. The
regression model obtained previously for a
2-year period was applied to each of these
windows. The β-coefﬁcient for the effect of the
natural logarithm of endotoxin on illness
episodes and total illness days along with its
95% conﬁdence interval were graphed against
the size of the window.
Results
The characteristics of the 332 children, overall
and stratiﬁed by bedroom airborne endotoxin
level, are presented in Tables 1 and 2. Of the
categorical variables (Table 1), only year of
testing was signiﬁcantly associated with endo-
toxin, with no secular trends (p < 0.0001). The
pets variable was not associated with endotoxin
concentrations. For dogs, the geometric mean
and geometric standard deviation (GSD) were
0.46 ± 3.82 if dogs were never reported present
in the home and 0.54 ± 3.15 if ever reported to
be in the home (p = 0.22). There was also no
significant difference in endotoxin values
between homes where dogs were reported in
< 50% of interviews compared with at least
50% of interviews (p = 0.12). Similarly, there
was no significant association between cats
and endotoxin. Of the continuous variables
(Table 2), only indoor relative humidity was
positively related to endotoxin (p = 0.01).
Illness episodes correlated best with the
individual symptoms of cough and stuffy nose;
Pearson correlation coefﬁcients were 0.69 and
0.76, respectively, both at p < 0.01. For illness
days, respective values were 0.83 and 0.95.
Wheeze was also significant for both illness
episodes and illness days at 0.37 and 0.41,
respectively (p < 0.01). The annualized num-
ber of respiratory illness episodes and total days
of illness episodes were positively related to
endotoxin at p = 0.13 and p = 0.07, respec-
tively (Table 3). All of the individual respira-
tory symptoms were greater in the higher
compared with the lower endotoxin group, but
only the incidence of wheeze reached statistical
signiﬁcance, being a relative 248% greater in
the higher compared with the lower endotoxin
group (p = 0.01).
The unadjusted Pearson correlation coefﬁ-
cients between log-transformed endotoxin and
illness episodes and illness days were 0.105
(p = 0.056) and 0.106 (p = 0.053), respectively.
The association for number of days with
wheeze was 0.271 (p < 0.0001), but other indi-
vidual variables were not significant at p =
0.05. The adjusted associations for illness
episodes and total illness days were highly sig-
niﬁcant (Tables 4 and 5). The multiple linear
regression model for illness episodes resulted in
a β-coefﬁcient of 0.46 (SE 0.13) for the natural
logarithm of endotoxin (p = 0.0003), which
means that each 1.0 unit increase in the natural
logarithm of airborne endotoxin concentration
was associated with 0.46 more illness episodes
per year. An alternative expression of the rela-
tion would be that a doubling of air endotoxin
concentration was associated with an increase
of 0.32 illness episodes per year (p = 0.0003),
adjusted for age, year of study, breast-feeding,
environmental tobacco smoke, child care atten-
dance, indoor temperature, and income. Also,
starting from the geometric mean (0.49) and
increasing endotoxin by its geometric mean
resulted in 4.7% excess illnesses per year.
Similarly, doubling air endotoxin was associ-
ated with an increase of 3.25 illness days per
year (p = 0.005), adjusted for age, year of
study, breast-feeding, child care attendance,
indoor temperature, and sex. Starting from the
geometric mean (0.49) and increasing endo-
toxin by its geometric mean resulted in 5.5%
excess illness days per year.
Signiﬁcant covariates in the regression of
illness episodes were year of testing, indoor
temperature, age, child care, environmental
tobacco smoke, and income (all p < 0.05).
Similar results were found with illness days with
a β-coefﬁcient of 4.68 (SE 1.66, p = 0.005).
In Figure 1, the β-coefﬁcient for the effect
of the natural logarithm of endotoxin on ill-
ness episodes and total illness days is graphed
against the size of the window. The magnitude
of the association between illness episodes and
endotoxin levels was almost linearly decreasing
Dales et al.
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Table 2. Characteristics of children’s home environments overall and stratiﬁed by terciles of endotoxin.
Overall 1st tercile 2nd tercile 3rd tercile
Variable No. Mean ± SD No. Mean ± SD No. Mean ± SD No. Mean ± SD p-Valuea
Children
Age (days) 332 351 ± 42.1 111 355 ± 34.9 110 337 ± 59.0 111 360 ± 19.6 0.38
Mean hours/week child care 332 7.89 ± 8.97 111 8.43 ± 9.18 110 7.65 ± 8.48 111 7.60 ± 9.28 0.49
Percent postnatal interviews where 332 30.1 ± 26.7 111 31.0 ± 25.4 110 29.2 ± 29.5 111 29.9 ± 25.1 0.78
breast-feeding reported
Environment
Endotoxin (EU/m3) 332 0.49b ± 3.49c 111 0.14b ± 2.32c 110 0.50b ± 1.32c 111 1.80b ± 2.10c —
Living room ergosterol (ng/m3) 319 0.15b ± 4.12c 107 0.16b ± 3.94c 105 0.16b ± 3.84c 107 0.14b ± 4.63c 0.40d
Bedroom ergosterol (ng/m3) 319 0.14b ± 4.24c 106 0.14b ± 4.14c 105 0.15b ± 3.93c 108 0.14b ± 4.71c 0.81d
Temperature (°C) 332 20.9 ± 2.32 111 20.9 ± 2.24 110 20.7 ± 2.15 111 21.0 ± 2.33 0.97
Relative humidity (%) 332 31.5 ± 6.24 111 30.8 ± 5.74 110 31.5 ± 5.80 111 33.0 ± 6.52 0.01
Interior wood storage (m3) 332 1.54 ± 4.39 111 1.12 ± 3.82 110 1.81 ± 5.01 111 1.70 ± 4.26 0.33
Mold area rank (%) 332 51.3 ± 29.3 111 50.3 ± 29.1 110 51.4 ± 30.5 111 50.7 ± 28.2 0.93
ap-Value of the Fisher test for a linear trend for the terciles of endotoxin. bGeometric mean. cGeometric SD. dp-Value of the Fisher test for a linear trend for the terciles of endotoxin using
the natural logarithm of the variable.
Table 3. Incidence of children’s illness overall and stratiﬁed by terciles of endotoxin concentrations.
Overall 1st tercile 2nd tercile 3rd tercile
Variable No. Mean ± SD No. Mean ± SD No. Mean ± SD No. Mean ± SD p-Valuea
No. of episodes of any illnessb per year 332 6.83 ± 2.80 111 6.66 ± 2.86 110 6.60 ± 2.65 111 7.22 ± 2.85 0.13
No. of illness days per year 332 58.5 ± 36.4 111 54.6 ± 34.4 110 57.5 ± 36.4 111 63.5 ± 38.0 0.07
No. of days with cough per year 332 33.0 ± 25.3 111 31.9 ± 23.8 110 31.0 ± 24.4 111 36.1 ± 27.6 0.21
No. of days with wheeze per year 332 4.06 ± 9.66 111 2.28 ± 4.55 110 4.26 ± 10.1 111 5.66 ± 12.4 0.01
No. of days with SOB per year 332 0.41 ± 1.20 111 0.30 ± 0.99 110 0.48 ± 1.25 111 0.46 ± 1.33 0.30
No. of days with stuffy nose per year 332 48.7 ± 31.2 111 46.1 ± 29.7 110 48.1 ± 31.3 111 51.9 ± 32.7 0.17
SOB, shortness of breath.
ap-Value of the Fisher test for a linear trend for the terciles of endotoxin. bIllnesses are cough, wheeze, shortness of breath, and stuffy nose. See “Materials and Methods” for details on
how we deﬁned illness episodes.with the use of longer observation periods
extending further from the original sampling.
Because the effect of endotoxin levels on ill-
ness episodes was highly significant for a
2-year period, it would be even more signiﬁ-
cant for shorter observation periods.
Discussion
Air endotoxin was positively associated with
an increase in episodes of respiratory illness
among children during their ﬁrst 2 years of life
despite adjustment for many host and envi-
ronmental factors, including indicators of fun-
gal exposure. The method of endotoxin
collection is unique compared with previous
studies of indoor air, most of which sampled
floor dust rather than airborne dust, which
may be better correlated with inhalation expo-
sure. Air sampling, done infrequently in previ-
ous studies, usually consisted of a grab sample
(up to 30 min), whereas our 5-day collection
period would be expected to provide a more
stable average estimate of exposure. Another
unique feature of exposure is that endotoxin
sampling was done during the cold season
when the ground is frozen and usually snow
covered. This makes it less likely that the meas-
ured endotoxin in air is simply a reﬂection of
what was present outdoors at the time of the
sampling. Rylander (2002) suggested that fun-
gal products, and specifically (1–3)-β-D-glu-
can, may coexist with endotoxins and thus may
confound the association. In the present study,
ergosterol, a marker of fungal growth in Prince
Edward Island homes, did not influence the
illness–endotoxin association.
Michel et al. (1991) measured endotoxin
concentrations in the house dust of 28 adult
subjects with chronic stable asthma. Exposure
to higher levels (> 5.6 ng lipopolysaccha-
ride/mL) was associated with poorer asthma
control measured by symptoms, medication
use, and lung function. In a subsequent study,
Michel et al. (1996) refined their previous
ﬁndings in a group of 69 adults with asthma
who were sensitized to house dust mites.
Asthma control was related to house dust
endotoxin, averaging 2 ng/mg dust in those
exposed to Der p 1 levels > 10 µg/g dust, but
not in those exposed to lower levels of the
major dust mite antigen. Rizzo et al. (1997)
and Douwes et al. (2000) reported adverse
effects of settled dust endotoxin in school-age
children with asthma, atopy, or asthma symp-
toms but not in those without an atopic his-
tory. Park et al. (2001a) and Gehring et al.
(2001a) reported increased wheezing in infants
living in homes with increased levels of settled
dust endotoxin, consistent with the findings
of the present study in which airborne endo-
toxin was measured and fungal burden was
accounted for using airborne ergosterol. Indoor
fungus therefore is not likely to have con-
founded the observed relation, although fun-
gus has been associated with respiratory
symptoms and may be associated with indoor
endotoxin (Gehring et al. 2001b; Verhoeff and
Burge 2004). Compared with occupational
settings, the indoor air endotoxin concen-
trations in our study were low (on average,
< 2 EU/m3), yet associations with adverse
health effects were observed. The relatively
large sample size with daily symptom monitor-
ing over 2 years in each subject appeared to
give us the power to detect these effects.
Further support from health effects at low
levels comes from Park et al. (2000), who
reported airborne endotoxin in Boston homes
during the warm season to be generally
< 1 EU/m3, and corresponding ﬂoor dust was
< 100 EU/mg (estimated values taken from a
log–scaled graph). Before our study, Park et al.
(2001a) also found associations between settled
dust endotoxin and wheeze.
Endotoxins are also postulated to confer
health beneﬁts. Lipopolysaccharide, the main
component of endotoxin, may shift the
cytokine response toward a Th1 response and
away from a Th2 response, thereby reducing
the chance of developing atopy (Lapa e Silva
et al. 2000). Consistent with this theory is the
observation that children growing up on farms,
where endotoxin exposure is higher than in
urban areas, have less atopy (Von Ehrenstion
et al. 2000; Von Mutius et al. 2000). Evidence
thus far suggests that early childhood exposure
to endotoxin may protect against future
asthma, but later in life endotoxin appears to
exacerbate asthma (Reed and Milton 2001).
The present study indicates that very early
exposure is not benign but associated with
increased illness episodes. Litonjua et al. (2002)
reported on 226 children between the ages of 1
and 5 years with a parental history of atopy
who were followed for 4 years. House dust
endotoxin was associated with reported wheez-
ing that decreased with increasing duration of
follow-up. This observation suggests that early
exposure offers future protection, or that the
initial endotoxin measure became less represen-
tative of ongoing endotoxin exposure over
time. The present study was somewhat differ-
ent: beginning at birth, including all children
Endotoxin and respiratory illness
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Table 4. Association between illness episodes
(dependent variable) and natural logarithm of endo-
toxin concentrations: multiple linear regression
analysis.
Independent variable β SE p-Value
Unadjusted (model R2 = 0.01)
Intercept 6.99 0.18 < 0.0001
Ln(endotoxin) 0.24 0.12 0.0556
Adjusted (model R2 = 0.18)
Intercept 7.74 1.92 < 0.0001
Ln(endotoxin) 0.46 0.13 0.0003
Year tested 0.0001
1998 –0.77 0.55 0.1645
1999 –1.23 0.55 0.0269
2000 –0.37 0.56 0.5019
2001 1.18 0.55 0.0321
2002 –0.90 0.52 0.0881
2003 Reference
Temperature –0.21 0.06 0.0012
Age 0.01 0.004 0.0038
Breast-feeding 0.94 0.58 0.1031
Child care 0.04 0.02 0.0200
Exposure to smoke 0.0483
Low –0.70 0.39 0.0757
Medium 0.17 0.37 0.6358
High Reference
Income 0.0204
< $30,000 –0.57 0.41 0.1614
$30,000–49,999 –0.93 0.33 0.0056
≥ $50,000 Reference
Table 5. Association between illness days (depen-
dent variable) and natural logarithm of endotoxin
concentrations: multiple linear regression analysis.
Independent variable β SE p-Value
Unadjusted (model R2 = 0.01)
Intercept 60.7 2.28 < 0.0001
Ln(endotoxin) 3.09 1.59 0.0533
Adjusted (model R2 = 0.15)
Intercept 47.3 24.7 0.0565
Ln(endotoxin) 4.68 1.66 0.0050
Year tested
1998 –1.50 6.90 0.8279
1999 –4.88 7.01 0.4863
2000 4.77 7.08 0.5003
2001 13.2 7.17 0.0674
2002 –7.77 6.78 0.2528
2003 Reference
Temperature –2.73 0.85 0.0014
Age 0.16 0.05 0.0029
Breast-feeding 0.70 0.22 0.0013
Child care 18.3 7.45 0.0147
Sex (male) 7.36 3.79 0.0533
Figure 1. The effect size over time between illness
and bedroom endotoxin measured at birth. (A)
Annualized illness episodes. (B) Annualized illness
days. Effect size is represented as the β-coefﬁcient
for the effect of the natural logarithm of endotoxin
on illness along with its 95% conﬁdence interval.
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irrespective of parental history of atopy, using
airborne rather than dust endotoxin, including
indicators of respiratory illness in addition
to wheeze, and considering confounding by
indoor mold exposure. Nevertheless, even
with children not selected based on atopic
parents, we also found that wheeze was the
symptom with the strongest association with
endotoxin, and the effect size became smaller
with increased duration of follow-up.
Sources of endotoxins. Gram-negative bac-
teria are found in water, soil, and outdoor air.
Reported indoor sources of gram-negative
include contaminated humidiﬁers, pets, stor-
age of food waste, and increased amounts of
settled dust (Park et al. 2001b). The need for
water availability is consistent with our ﬁnding
that relative humidity was positively associated
with air endotoxin, not previously described.
Gehring et al. (2001a) found that dust con-
centrations were higher with cats and dogs
present. These studies found that endotoxin
was higher in old buildings, with longer dura-
tion of occupancy, low ventilation rate, and
poor housekeeping. Indoor pets were not asso-
ciated with air endotoxin in the present study,
which was carried out during the cold season
with frozen ground and often snow cover.
Perhaps pets would be less likely to go outside
and subsequently bring in soil on their paws.
In summary, the present study supports a
positive association between airborne endotoxins
and the incidence of acute respiratory illnesses
during the ﬁrst 2 years of life, independent of
allergic history and exposure to indoor mold that
may coexist with contamination by bacterial
endotoxin.
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